Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 1,534,100 | 1,480,900 | 1,530,200 | 1,459,600 | 1,348,300 |
| Cost of Goods | 356,900 | 350,400 | 343,000 | 329,500 | 257,900 |
| Gross Profit | 1,177,200 | 1,130,500 | 1,187,200 | 1,130,100 | 1,090,400 |
| Operating Expenses | 778,000 | 712,500 | 860,000 | 742,200 | 643,500 |
| Operating Income | 400,100 | 418,400 | 327,200 | 388,400 | 447,800 |
| Other Income | 21,600 | 20,900 | 11,300 | 10,200 | 11,500 |
| Pre-tax Income | 421,700 | 439,300 | 338,500 | 398,600 | 459,300 |
| Income Tax | 52,000 | 55,600 | 33,000 | 58,100 | 60,900 |
| Net Income Continuous | 369,700 | 383,700 | 305,500 | 340,500 | 398,400 |
| Minority Interests | -200 | -1,200 | -1,600 | N/A | N/A |
| Net Income | $369,900 | $384,900 | $307,100 | $340,500 | $398,400 |
| EPS Basic Total Ops | 0.61 | 0.63 | 0.51 | 0.56 | 0.66 |
| EPS Basic Continuous Ops | 0.61 | 0.63 | 0.50 | 0.56 | 0.65 |
| EPS Diluted Total Ops | 0.61 | 0.63 | 0.50 | 0.56 | 0.65 |
| EPS Diluted Continuous Ops | 0.61 | 0.63 | 0.50 | 0.56 | 0.65 |
| EPS Diluted Before Non-Recurring Items | 0.64 | 0.59 | 0.66 | 0.62 | 0.64 |
| EBITDA(a) | $436,800 | $455,300 | $363,300 | $423,600 | $483,200 |